Cargando…
This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients
The increasing use and effectiveness of primary systemic treatment (PST) enables tailored locoregional treatment. About one third of clinically node positive (cN+) breast cancer patients achieve pathologic complete response (pCR) of the axilla, with higher rates observed in Human Epidermal growth fa...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432821/ https://www.ncbi.nlm.nih.gov/pubmed/37562108 http://dx.doi.org/10.1016/j.breast.2023.06.011 |